CSE | FSE

novamentis life science

Strategic Investing

A Canadian-based public company that builds and supports a diversified portfolio of health and wellness businesses. Aiming to be an industry leader in the development of objective biologic endpoints to validate subjective behavioral changes in people receiving psychedelic therapy.

 

Our Holdings

novamentis biotech

Nova Mentis Biotech

Wholly owned subsidiary investigating medicinal psychedelics. Current focus indications: obesity, diabetes, liver disease (NASH)

Learn More


Pilz BioScience

Pilz Bioscience

Wholly owned subsidiary investigating medicinal psychedelics. Current focus indications: Autism Spectrum Disorder

Learn More

Nova Mentis Life Science
Stock Performance

CSE FSE

Latest News

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study
Develops Microbiome Diagnostic Index

Vancouver, British Columbia – January 26, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has commenced the diagnostic and treatment phase of its ongoing preclinical model study of autism spectrum disorder (ASD).   In this model, which is well accepted by neuroscientists, pregnant rats are exposed to valproic acid (VPA) and the resultant offspring have ASD behavioral symptoms. 

NOVA had previously identified statistically significant changes in ...

Nova Mentis to be Listed in the First-Ever Psychedelic Index

Vancouver, British Columbia – January 25, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has been included in the world’s first North American Psychedelic Index. Based on this index, The Horizon Psychedelic Stock Index ETF is expected to commence trading Jan. 27, 2021 under ticker “PSYK” on the NEO Exchange.

“NOVA is developing psilocybin and mushroom-based tryptamine derivatives for the treatment of autism spectrum disorder (ASD), an unmet medical need. We have started a preclinical study in a ...